BRCA1 and breast carcinoma: An expanding database of evidence suggests that miR-155’s activity in breast cancer (BC) is linked to BRCA1, as the absence of functional BRCA1 has been shown to elevate miR-155 expression levels, and conversely, by direct targeting of the miR-155 promoter [19].